|
Association of PI-RADS categories and PSA density with active surveillance progression in patients with prostate cancer. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Patents, Royalties, Other Intellectual Property - Patent: System and Method for Evaluation of Disease Burden |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Patents, Royalties, Other Intellectual Property - Royalties from US Government patents for MRI-US fusion biopsy, computer aided diagnosis software |
Other Relationship - Navidea; Philips Healthcare |
|
|
No Relationships to Disclose |
|
|
Patents, Royalties, Other Intellectual Property - I am a patent holder for MRI-Ultrasound fusion technology licensed to InVivo which markets it as UroNav. However, as a government employee I personally receive no financial benefit from this patent. |
Other Relationship - Aspyrian Therapeutics; GE Healthcare; Philips Healthcare |
|
|
Patents, Royalties, Other Intellectual Property - NIH and Philips have a CRADA. NIH has intellectual property in the field, including among other patents and patent applications, Patent: “System, methods, and instrumentation for image guided prostate treatment” US Patent number: 8948845, with inventors/a |